NCT02484287

Brief Summary

The purpose and/or hypothesis: To decrease the amount of external ventricular drain (EVD) related catheter infections by comparing the efficacy of Oklahoma University Medicine standard EVD catheters, both impregnated and non-impregnated, in three principle areas: incidence of infection, cost analysis, and average durations of placement, all while maintaining the standards of technique.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 29, 2015

Completed
9 months until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 12, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 12, 2018

Completed
5 years until next milestone

Results Posted

Study results publicly available

July 3, 2023

Completed
Last Updated

July 3, 2023

Status Verified

June 1, 2023

Enrollment Period

2.3 years

First QC Date

June 23, 2015

Results QC Date

November 4, 2021

Last Update Submit

June 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Infection Rates of EVD Patients

    Infection rates of EVD patients

    24 months

Other Outcomes (2)

  • Duration of EVD Placement

    24 Months

  • Cost

    24 months

Study Arms (3)

Integra External Drainage Catheter

ACTIVE COMPARATOR

The Integra External Drainage Catheter non antibiotic-impregnated EVD catheter

Device: The Integra External Drainage Catheter.

Ventriclear EVD Antibiotic Catheter

ACTIVE COMPARATOR

The Ventriclear EVD Antibiotic Catheter antibiotic-impregnated EVD catheter

Device: The Ventriclear EVD Antibiotic Catheter

Codman Bactiseal EVD Catheter Set

ACTIVE COMPARATOR

The Codman Bactiseal EVD Catheter Set antibiotic-impregnated EVD catheter

Device: The Codman Bactiseal EVD Catheter Set

Interventions

Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.

Integra External Drainage Catheter

Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.

Ventriclear EVD Antibiotic Catheter

Participants will be randomly assigned to receive 1 of 3 drains, to determine the efficacy of antibiotic-impregnated vs non antibiotic-impregnated EVD catheters, in the reduction of infection rates associated with EVD use.

Codman Bactiseal EVD Catheter Set

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who require placement of external ventricular drain.

You may not qualify if:

  • Prisoners and/or those who may be pregnant.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oklahoma University Medical Center

Oklahoma City, Oklahoma, 73104, United States

Location

Related Publications (6)

  • Bohnstedt BN, Ziemba-Davis M, Edwards G, Brom J, Payner TD, Leipzig TJ, Scott JA, DeNardo AJ, Palmer E, Cohen-Gadol AA. Treatment and outcomes among 102 posterior inferior cerebellar artery aneurysms: a comparison of endovascular and microsurgical clip ligation. World Neurosurg. 2015 May;83(5):784-93. doi: 10.1016/j.wneu.2014.12.035. Epub 2014 Dec 23.

    PMID: 25541085BACKGROUND
  • Lane B, Bohnstedt BN, Cohen-Gadol AA. A prospective comparative study of microscope-integrated intraoperative fluorescein and indocyanine videoangiography for clip ligation of complex cerebral aneurysms. J Neurosurg. 2015 Mar;122(3):618-26. doi: 10.3171/2014.10.JNS132766. Epub 2014 Dec 19.

    PMID: 25526265BACKGROUND
  • Kulwin C, Bohnstedt BN, Payner TD, Leipzig TJ, Scott JA, DeNardo AJ, Cohen-Gadol AA. Aneurysmal acute subdural hemorrhage: prognostic factors associated with treatment. J Clin Neurosci. 2014 Aug;21(8):1333-6. doi: 10.1016/j.jocn.2013.12.010. Epub 2014 Jan 24.

    PMID: 24679648BACKGROUND
  • Ziemba-Davis M, Bohnstedt BN, Payner TD, Leipzig TJ, Palmer E, Cohen-Gadol AA. Incidence, epidemiology, and treatment of aneurysmal subarachnoid hemorrhage in 12 midwest communities. J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1073-82. doi: 10.1016/j.jstrokecerebrovasdis.2013.09.010. Epub 2013 Oct 19.

    PMID: 24144595BACKGROUND
  • Cohen-Gadol AA, Bohnstedt BN. Recognition and evaluation of nontraumatic subarachnoid hemorrhage and ruptured cerebral aneurysm. Am Fam Physician. 2013 Oct 1;88(7):451-6.

    PMID: 24134085BACKGROUND
  • Bohnstedt BN, Nguyen HS, Kulwin CG, Shoja MM, Helbig GM, Leipzig TJ, Payner TD, Cohen-Gadol AA. Outcomes for clip ligation and hematoma evacuation associated with 102 patients with ruptured middle cerebral artery aneurysms. World Neurosurg. 2013 Sep-Oct;80(3-4):335-41. doi: 10.1016/j.wneu.2012.03.008. Epub 2012 Mar 30.

    PMID: 22465372BACKGROUND

MeSH Terms

Conditions

Catheter-Related Infections

Condition Hierarchy (Ancestors)

Infections

Limitations and Caveats

Recruitment was halted prematurely, due to changes in key study personnel. PI left prior to completing final data analysis.

Results Point of Contact

Title
Blair Apple
Organization
University of Oklahoma Health Science Center

Study Officials

  • Ahmed A Cheema, MD

    Associate Professor

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2015

First Posted

June 29, 2015

Study Start

April 1, 2016

Primary Completion

July 12, 2018

Study Completion

July 12, 2018

Last Updated

July 3, 2023

Results First Posted

July 3, 2023

Record last verified: 2023-06

Locations